Aperio Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Aperio Group’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	$3.52M	Sell	40,132 -5,398	-12%	-$473K	0.01%	989
2020 Q3	$3.46M	Sell	45,530 -2,707	-6%	-$206K	0.01%	879
2020 Q2	$5.95M	Buy	48,237 +2,188	+5%	+$270K	0.02%	665
2020 Q1	$3.89M	Buy	46,049 +11,980	+35%	+$1.01M	0.02%	758
2019 Q4	$2.88M	Sell	34,069 -1,499	-4%	-$127K	0.01%	932
2019 Q3	$2.4M	Sell	35,568 -27,601	-44%	-$1.86M	0.01%	975
2019 Q2	$5.41M	Buy	63,169 +7,370	+13%	+$631K	0.02%	686
2019 Q1	$4.96M	Sell	55,799 -2,378	-4%	-$211K	0.02%	705
2018 Q4	$4.95M	Sell	58,177 -2,001	-3%	-$170K	0.03%	647
2018 Q3	$5.84M	Sell	60,178 -801	-1%	-$77.7K	0.03%	625
2018 Q2	$5.74M	Buy	60,979 +7,756	+15%	+$731K	0.03%	612
2018 Q1	$4.32M	Sell	53,223 -347	-0.6%	-$28.1K	0.02%	705
2017 Q4	$4.78M	Buy	53,570 +147	+0.3%	+$13.1K	0.02%	655
2017 Q3	$4.97M	Sell	53,423 -3,068	-5%	-$286K	0.03%	612
2017 Q2	$5.13M	Buy	56,491 +5,006	+10%	+$455K	0.03%	567
2017 Q1	$4.52M	Buy	51,485 +2,492	+5%	+$219K	0.03%	588
2016 Q4	$4.06M	Sell	48,993 -1,294	-3%	-$107K	0.03%	581
2016 Q3	$4.65M	Buy	50,287 +5,488	+12%	+$508K	0.03%	561
2016 Q2	$3.49M	Buy	44,799 +142	+0.3%	+$11K	0.03%	629
2016 Q1	$3.68M	Buy	44,657 +12,688	+40%	+$1.05M	0.03%	586
2015 Q4	$3.35M	Buy	31,969 +5,364	+20%	+$562K	0.03%	580
2015 Q3	$2.8M	Buy	26,605 +5,148	+24%	+$542K	0.03%	616
2015 Q2	$2.94M	Buy	21,457 +3,335	+18%	+$456K	0.03%	588
2015 Q1	$2.26M	Buy	18,122 +3,298	+22%	+$411K	0.03%	640
2014 Q4	$1.34M	Buy	14,824 +2,742	+23%	+$248K	0.02%	782
2014 Q3	$872K	Buy	12,082 +975	+9%	+$70.4K	0.01%	911
2014 Q2	$691K	Buy	11,107 +609	+6%	+$37.9K	0.01%	991
2014 Q1	$716K	Buy	+10,498	New	+$716K	0.01%	1163
2013 Q4	–	Sell	-7,181	Closed	-$518K	–	1091
2013 Q3	$518K	Buy	7,181 +2,772	+63%	+$200K	0.01%	1129
2013 Q2	$246K	Buy	+4,409	New	+$246K	0.01%	1389